Literature DB >> 8728706

Clinical heterogeneity in hereditary haemorrhagic telangiectasia: are pulmonary arteriovenous malformations more common in families linked to endoglin?

J N Berg1, A E Guttmacher, D A Marchuk, M E Porteous.   

Abstract

Pulmonary arteriovenous malformations (PAVMs) occur in up to 27% of patients with hereditary haemorrhagic telangiectasia (HHT) and are associated with a rate of paradoxical cerebral embolism at presentation of up to 36%. At least two different loci have been shown for HHT. Mutations in endoglin have been found in some families and the locus designated ORW1. In other families this locus has been excluded. In this paper we confirm that in families linked to ORW1 there is a prevalence of PAVMs among affected members of 29.2%, compared to a prevalence of 2.9% in families in which this locus has been excluded (chi 2 = 19.2, p < 0.001). This information can be used to decide how to screen HHT patients for PAVMs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8728706      PMCID: PMC1051882          DOI: 10.1136/jmg.33.3.256

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  13 in total

1.  Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population.

Authors:  H Plauchu; J P de Chadarévian; A Bideau; J M Robert
Journal:  Am J Med Genet       Date:  1989-03

2.  A second locus for hereditary hemorrhagic telangiectasia maps to chromosome 12.

Authors:  D W Johnson; J N Berg; C J Gallione; K A McAllister; J P Warner; E A Helmbold; D S Markel; C E Jackson; M E Porteous; D A Marchuk
Journal:  Genome Res       Date:  1995-08       Impact factor: 9.043

3.  A gene for hereditary haemorrhagic telangiectasia maps to chromosome 9q3.

Authors:  C L Shovlin; J M Hughes; E G Tuddenham; I Temperley; Y F Perembelon; J Scott; C E Seidman; J G Seidman
Journal:  Nat Genet       Date:  1994-02       Impact factor: 38.330

4.  A disease locus for hereditary haemorrhagic telangiectasia maps to chromosome 9q33-34.

Authors:  M T McDonald; K A Papenberg; S Ghosh; A A Glatfelter; B B Biesecker; E A Helmbold; D S Markel; A Zolotor; W C McKinnon; J L Vanderstoep
Journal:  Nat Genet       Date:  1994-02       Impact factor: 38.330

5.  Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy.

Authors:  R I White; A Lynch-Nyhan; P Terry; P C Buescher; E J Farmlett; L Charnas; K Shuman; W Kim; M Kinnison; S E Mitchell
Journal:  Radiology       Date:  1988-12       Impact factor: 11.105

6.  Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1.

Authors:  K A McAllister; K M Grogg; D W Johnson; C J Gallione; M A Baldwin; C E Jackson; E A Helmbold; D S Markel; W C McKinnon; J Murrell
Journal:  Nat Genet       Date:  1994-12       Impact factor: 38.330

7.  Linkage of hereditary haemorrhagic telangiectasia to chromosome 9q34 and evidence for locus heterogeneity.

Authors:  P Heutink; T Haitjema; G J Breedveld; B Janssen; L A Sandkuijl; C J Bontekoe; C J Westerman; B A Oostra
Journal:  J Med Genet       Date:  1994-12       Impact factor: 6.318

8.  Genetic heterogeneity in hereditary haemorrhagic telangiectasia: possible correlation with clinical phenotype.

Authors:  K A McAllister; F Lennon; B Bowles-Biesecker; W C McKinnon; E A Helmbold; D S Markel; C E Jackson; A E Guttmacher; M A Pericak-Vance; D A Marchuk
Journal:  J Med Genet       Date:  1994-12       Impact factor: 6.318

9.  Hereditary haemorrhagic telangiectasia: a clinical analysis.

Authors:  M E Porteous; J Burn; S J Proctor
Journal:  J Med Genet       Date:  1992-08       Impact factor: 6.318

Review 10.  Intrapulmonary shunts: coils to transplantation.

Authors:  J M Hughes
Journal:  J R Coll Physicians Lond       Date:  1994 May-Jun
View more
  25 in total

Review 1.  Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms.

Authors:  C L Shovlin; M Letarte
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

2.  Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia.

Authors:  T G W Letteboer; J J Mager; R J Snijder; B P C Koeleman; D Lindhout; J K Ploos van Amstel; C J J Westermann
Journal:  J Med Genet       Date:  2005-09-09       Impact factor: 6.318

3.  Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1.

Authors:  A Bourdeau; U Cymerman; M E Paquet; W Meschino; W C McKinnon; A E Guttmacher; L Becker; M Letarte
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

4.  Endoglin and Alk5 regulate epithelial-mesenchymal transformation during cardiac valve formation.

Authors:  Melania E Mercado-Pimentel; Antony D Hubbard; Raymond B Runyan
Journal:  Dev Biol       Date:  2006-12-23       Impact factor: 3.582

5.  Three novel mutations in the activin receptor-like kinase 1 (ALK-1) gene in hereditary hemorrhagic telangiectasia type 2 in Brazilian patients.

Authors:  A M Assis; F F Costa; V R Arruda; J M Annichino-Bizzacchi; C S Bertuzzo
Journal:  J Hum Genet       Date:  2007-01-12       Impact factor: 3.172

6.  Potential role of modifier genes influencing transforming growth factor-beta1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia.

Authors:  A Bourdeau; M E Faughnan; M L McDonald; A D Paterson; I R Wanless; M Letarte
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

7.  Endothelial signaling and the molecular basis of arteriovenous malformation.

Authors:  Deepak Atri; Bruno Larrivée; Anne Eichmann; Michael Simons
Journal:  Cell Mol Life Sci       Date:  2013-09-28       Impact factor: 9.261

8.  Visceral manifestations in hereditary haemorrhagic telangiectasia type 2.

Authors:  S A Abdalla; U W Geisthoff; D Bonneau; H Plauchu; J McDonald; S Kennedy; M E Faughnan; M Letarte
Journal:  J Med Genet       Date:  2003-07       Impact factor: 6.318

9.  Hereditary hemorrhagic telangiectasia in Japanese patients.

Authors:  Masaki Komiyama; Tomoya Ishiguro; Osamu Yamada; Hiroko Morisaki; Takayuki Morisaki
Journal:  J Hum Genet       Date:  2013-11-07       Impact factor: 3.172

10.  Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative.

Authors:  N Pece; S Vera; U Cymerman; R I White; J L Wrana; M Letarte
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.